Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma
| Author | Takashi Himoto | en |
| Author | Kazutaka Kurokohchi | en |
| Author | Seishiro Watanabe | en |
| Author | Tsutomu Masaki | en |
| Issued Date | 2012-10-10 | en |
| Abstract | Contexts: Hepatocellular carcinoma (HCC) is one of the most common malignant diseases in the world. Because less than 20% of patients with HCC are resectable, various types of non-surgical treatment have been developed. Evidence Acquisition: At present, radiofrequency ablation (RFA) is accepted as the standard local treatment for patients with HCC because of its superior local control and overall survival compared to other local treatments. Results: New devices for RFA and combination treatments of RFA with other procedures have been developed to improve anti-tumoral effects. Conclusions: This review mainly focuses on the status of RFA in the management of HCC and recent advances in RFA treatment technology. | en |
| DOI | https://doi.org/10.5812/hepatmon.5945 | en |
| Keyword | Carcinoma | en |
| Keyword | Hepatocellular | en |
| Keyword | Treatment | en |
| Keyword | Catheter Ablation | en |
| Publisher | Brieflands | en |
| Title | Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma | en |
| Type | Review Article | en |